ResearcherNankai UniversityActive in the last 2 years
Cuizhu Zhang
Matched on ORCID iD 0009-0007-6722-8180; OpenAlex author ID A5048723811. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 5
- Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer. Last author DOI 10.1016/j.omton.2025.201021↗
- An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Last author DOI 10.1016/j.bbrc.2024.149931↗
- 4-1BBL-Armed Oncolytic Herpes Simplex Virus Exerts Antitumor Effects in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/vaccines12121309↗
- CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell… Co-author DOI 10.1136/jitc-2021-003809↗
- Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ymthe.2020.10.027↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Youjia Cao · 4 shared papers, 2021–2025 · strength 0.66
- Paper Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic can… DOI 10.1016/j.omton.2025.201021↗
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Paper CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microe… DOI 10.1136/jitc-2021-003809↗
- Hongkai Zhang · 3 shared papers, 2021–2024 · strength 0.45
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Paper CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microe… DOI 10.1136/jitc-2021-003809↗
- Paper Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.ymthe.2020.10.027↗
- Jiliang Zhao · 2 shared papers, 2024–2025 · strength 0.41
- Paper Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic can… DOI 10.1016/j.omton.2025.201021↗
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Feilong Zhou · 2 shared papers, 2024–2025 · strength 0.41
- Paper Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic can… DOI 10.1016/j.omton.2025.201021↗
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Ruikun Wang · 2 shared papers, 2021–2022 · strength 0.25
- Paper CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microe… DOI 10.1136/jitc-2021-003809↗
- Paper Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.ymthe.2020.10.027↗
- Wenrui Gao · 1 shared paper, 2024 · strength 0.22
- Yuntao Zhang · 1 shared paper, 2024 · strength 0.22
- Shiyu Liu · 1 shared paper, 2022 · strength 0.13
- Liming Zhang · 1 shared paper, 2021 · strength 0.12
- Nianchao Zhang · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.